glp 1 and rheumatoid arthritis Targeting the GLP-1/GLP-1R axis to treat osteoarthritis: A new opportunity? Taking GLP-1 medications with methotrexate

Why cardiovascular disease persists: delayed treatment, insufficient thresholds, and missed opportunities for early intervention [22:00]

Their filing for FDA approval of CagriSema in early 2026 puts them on track for a potential approval decision by late 2026 or early 2027

Inhibition of ghrelin activity by receptor antagonist [d-Lys-3] GHRP-6 attenuates alcohol-induced hepatic steatosis by regulating hepatic lipid metabolism

This makes GLP-1 a more attractive target for treatment, leading to the development of several GLP-1 receptor agonists for managing type 2 diabetes, obesity, and potentially other conditions

Nutrients 15 , 174 (2022)

Studied use areas Research into anabolic and protein-synthesis signalling Muscle repair and recovery research after training-induced microdamage Cell growth, differentiation and tissue-adaptation research Body-composition research alongside GH-axis pathways Safety & status Educational information only not medical advice